Niel C. Hoglen

First-in-Class Pan Caspase Inhibitor Developed for the Treatment of Liver Disease

Steven D. Linton, Teresa Aja, Robert A. Armstrong et al. · Journal of Medicinal Chemistry · 2005 · 106 citations

Life Sciences, Pharmacokinetics, Pharmacology +14

Characterization of IDN-6556 (3-{2-(2-tert-Butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic Acid): a Liver-Targeted Caspase Inhibitor

Niel C. Hoglen, Long-Shiuh Chen, Craig D. Fisher et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 98 citations

Life Sciences, Pharmacokinetics, Pharmacology +16

The Role of Inflammatory Cells and Cytochrome P450 in the Potentiation of CCl4-Induced Liver Injury by a Single Dose of Retinol

Drew Badger, J-M. Sauer, Niel C. Hoglen et al. · Toxicology and Applied Pharmacology · 1996 · 77 citations

Medicine, Pharmacology, Toxicology +17

Reactions of Peroxynitrite with γ-Tocopherol

Niel C. Hoglen, Stephen Waller, I.G. Sipes et al. · Chemical Research in Toxicology · 1997 · 70 citations

Life Sciences, Biochemistry, Chemistry +10

Sodium Nitrite-Mediated Killing of the Major Cystic Fibrosis Pathogens <i>Pseudomonas aeruginosa</i> , <i>Staphylococcus aureus</i> , and <i>Burkholderia cepacia</i> under Anaerobic Planktonic and Biofilm Conditions

Tiffany A. Major, Warunya Panmanee, Joel E. Mortensen et al. · Antimicrobial Agents and Chemotherapy · 2010 · 62 citations · Full text

Life Sciences, Microbiology, Pharmacology +17